盈康生命股价跌5.04%，银河基金旗下1只基金重仓，持有81.32万股浮亏损失52.86万元

Group 1 - The core point of the news is that Yingkang Life's stock has experienced a decline of 5.04% on January 16, with a total market value of 9.181 billion yuan and a cumulative drop of 2.86% over three consecutive days [1] - Yingkang Life, established on August 6, 1998, and listed on December 9, 2010, is based in Qingdao, Shandong Province, and specializes in medical devices and services, particularly in cancer prevention, diagnosis, treatment, and rehabilitation [1] - The company's revenue composition shows that medical services account for 77.47%, while medical devices and consumables each contribute 22.53% [1] Group 2 - From the perspective of fund holdings, one fund under Galaxy Fund has a significant position in Yingkang Life, with a reduction of 117,700 shares in the third quarter, holding 813,200 shares, which represents 4.72% of the fund's net value [2] - The fund, Galaxy Kangle Stock A (519673), has reported a year-to-date return of 24.87% and a one-year return of 48.73%, ranking 13th out of 5,531 in its category [2] - The fund manager, Fang Wei, has been in position for 4 years and 253 days, with the fund's total asset size at 703 million yuan [3]